GR
Gangadhar Ramchandra Kakulate
About Gangadhar Ramchandra Kakulate
Data last updated:
Gangadhar Ramchandra Kakulate has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Kapynag Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kapynag Pharma Private Limited at ₹8.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kapynag Pharma Private Limited U51909MH2017PTC299496 | Director | 25 Jun 2022 | 2017 | ₹8.2 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gangadhar Ramchandra Kakulate
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gangadhar Ramchandra Kakulate
Gangadhar Ramchandra Kakulate has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Kapynag Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kapynag Pharma Private Limited at ₹8.2 Lakh (FY 2025).
Gangadhar Ramchandra Kakulate is associated with 1 company as Director, including Kapynag Pharma Private Limited (₹8.2 Lakh).
Gangadhar Ramchandra Kakulate has expertise in General Business.
Gangadhar Ramchandra Kakulate has 4 years in corporate governance.
By reported revenue, the largest current company of Gangadhar Ramchandra Kakulate is Kapynag Pharma Private Limited, with revenue of ₹8.2 Lakh (FY 2025).
Gangadhar Ramchandra Kakulate currently holds positions at 1 company: Kapynag Pharma Private Limited (₹8.2 Lakh).